CareCost Estimate
The Infusion Reimbursement Index · Q2 2026 · v2.0

Cigna

CareCost Research · Reviewed by Erin Rose

Scorecard

Grade
C
Index (ASP = 100)
100.0
Vs. acquisition
-2.6%
Brand index
100.0
Biosimilar index
107.8
Contract variability
Medium
Drugs observed
945
States
52

Contracts below the typical acquisition benchmark (102.7) on the median drug.

How this payer prices

On this filing, the median drug carries 12 distinct contracted rates across practices, with 96% of billing volume on the single most common rate — an effectively posted price.

Benchmarks: typical acquisition 102.7 · Medicare 104.3 after sequestration · 106 statutory (ASP = 100).

Contracted rates from insurers’ machine-readable files, not amounts paid on a claim.